Abstract
Ordinal longitudinal outcomes are becoming common in clinical research, particularly in the context of COVID‐19 clinical trials. These outcomes are information‐rich and can increase the statistical efficiency of a study when analyzed in a principled manner. We present Bayesian ordinal transition models as a flexible modeling framework to analyze ordinal longitudinal outcomes. We develop the theory from first principles and provide an application using data from the Adaptive COVID‐19 Treatment Trial (ACTT‐1) with code examples in R. We advocate that researchers use ordinal transition models to analyze ordinal longitudinal outcomes when appropriate alongside standard methods such as time‐to‐event modeling.
Funding Information
  • National Center for Advancing Translational Sciences (5UL1TR002243‐03, U24TR001608)

This publication has 31 references indexed in Scilit: